6533b831fe1ef96bd129832f

RESEARCH PRODUCT

Sarcopenia and Covid-19: A New Entity?

subject

description

As the world comes into terms with the persistent existence of the coronavirus disease 19 (COVID-19) pandemic, the scientific and medical communities have started shifting their attention to the long-term side effects of the disease. Specialists have acknowledged that numerous COVID-19 survivors, especially those who suffered severe complications and endured prolonged bedrest, may require continuous monitoring and rehabilitative care. In this chapter, the authors discuss factors that may predispose individuals to acute sarcopenia secondary to COVID-19 infection or sarcopenic obesity secondary to altered diet and physical activity from prolonged confinement. Challenges in nutrition are highlighted as well as aspects conducive to muscle strength and loss with respect to the COVID-19 era. Lastly, possible management strategies are presented in light of the limited but accumulating evidence on sarcopenia and COVID-19 treatment schemes.